Literature DB >> 3155958

In situ quantification of T-lymphocyte subsets and Langerhans cells in the inflammatory infiltrate of atopic eczema.

C B Zachary, M H Allen, D M MacDonald.   

Abstract

Tissue from the acute, non-infected eruption of sixteen atopic eczema subjects was subjected to an indirect immunoperoxidase technique using monoclonal antibodies recognizing T-lymphocyte subsets, Langerhans cells and natural killer cells. Over half the cells infiltrating the dermis were T lymphocytes, including a large majority of helper T cells and relatively few suppressor T cells. Langerhans cells were present in significant proportions in the dermis and probably reflected increased antigen presentation within the affected skin. There was no evidence of increased natural killer cell presence. This study suggests that type IV hypersensitivity may be implicated in the aetiology of atopic eczema.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3155958     DOI: 10.1111/j.1365-2133.1985.tb00078.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  14 in total

1.  Predominance of "memory" T cells (CD4+, CDw29+) over "naive" T cells (CD4+, CD45R+) in both normal and diseased human skin.

Authors:  J D Bos; C Hagenaars; P K Das; S R Krieg; W J Voorn; M L Kapsenberg
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

Review 2.  Dermatology.

Authors:  M H Rustin
Journal:  Postgrad Med J       Date:  1990-11       Impact factor: 2.401

3.  The pathology of atopic dermatitis.

Authors:  A K Tong; M C Mihm
Journal:  Clin Rev Allergy       Date:  1986-02

4.  Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis.

Authors:  Lin Chen; O Martinez; P Venkataramani; S-X Lin; B S Prabhakar; L S Chan
Journal:  Clin Exp Immunol       Date:  2005-02       Impact factor: 4.330

5.  Distribution of Langerhans cells in skin lesions of MRL/l mice.

Authors:  H Kanauchi; F Furukawa; Y Horiguchi; T Horio; S Imamura
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

6.  Interleukin 2 therapy in severe atopic dermatitis.

Authors:  K H Hsieh; C C Chou; S F Huang
Journal:  J Clin Immunol       Date:  1991-01       Impact factor: 8.317

7.  Increase in macrophage migration inhibitory factor levels in lacrimal fluid of patients with severe atopic dermatitis.

Authors:  Nobuyoshi Kitaichi; Tadamichi Shimizu; Ayumi Honda; Riichiro Abe; Kazuhiro Ohgami; Kenji Shiratori; Hiroshi Shimizu; Shigeaki Ohno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-12-06       Impact factor: 3.117

8.  Allergen presentation by epidermal Langerhans' cells from patients with atopic dermatitis is mediated by IgE.

Authors:  G C Mudde; F C Van Reijsen; G J Boland; G C de Gast; P L Bruijnzeel; C A Bruijnzeel-Koomen
Journal:  Immunology       Date:  1990-03       Impact factor: 7.397

9.  Characterization of grass pollen reactive T-cell lines derived from lesional atopic skin.

Authors:  C Ramb-Lindhauer; A Feldmann; M Rotte; C Neumann
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

10.  Imbalance of CD4+CD29+ and CD4+CD45RA+ T-helper cell subsets in peripheral blood of patients with severe atopic dermatitis.

Authors:  K Jung; A Bittrich; V Klimmek; H Schubert
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.